Dr Reddys Laboratories Ltd (RDY) stock
RDYNYSEPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Score 7/30
$14.74+0.01 (+0.07%)
Close on Nov 13, 2026Market cap $12.30BP/E 26.9Yield 0.58%
Dr Reddys Laboratories total assets
Total assets on the balance sheet at the end of each period.
Dr Reddys Laboratories's total assets was ₹579.35B at Mar 31, 2026. For fiscal 2026 it was ₹579.35B, up 17.5% from the year before. The highest annual figure on record is ₹579.35B in fiscal 2026.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | ₹579.35B | +17.5% |
| FY2025 | Mar 31, 2025 | ₹492.99B | +27.2% |
| FY2024 | Mar 31, 2024 | ₹387.52B | +20.4% |
| FY2023 | Mar 31, 2023 | ₹321.85B | +9.9% |
| FY2022 | Mar 31, 2022 | ₹292.83B | +10.3% |
| FY2021 | Mar 31, 2021 | ₹265.49B | +14.3% |
| FY2020 | Mar 31, 2020 | ₹232.24B | +3.0% |
| FY2019 | Mar 31, 2019 | ₹225.43B | -0.1% |
| FY2018 | Mar 31, 2018 | ₹225.60B | +2.6% |
| FY2017 | Mar 31, 2017 | ₹219.82B | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | ₹579.35B | +97.8% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | ₹492.99B | +85.7% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | ₹387.52B | +66.9% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | ₹321.85B | +42.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | ₹292.83B | +29.8% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | ₹265.49B | +20.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | ₹232.24B | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | ₹225.43B | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | ₹225.60B | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | ₹219.82B | – |
See a number that looks wrong?